Adaptimmune Therapeutics Plc Is A Clinical Stage Biopharmaceutical Company Based In Abingdonoxfordshireukfounded In 2008The Company Specializes In Developing Engineered T Cell Receptortcrtherapies Aimed At Treating Various Cancersincluding Solid Tumors And Hematologic Cancersadaptimmune Operates As An Integrated Cell Therapy Organizationhandling Researchclinical Developmentmanufacturingand Commercialization The Company S Core Technology Involves Engineering High Affinity Tcrs That Target Cancer Specific Antigensallowing T Cells To Effectively Recognize And Destroy Tumorsadaptimmune S Pipeline Includes Several Promising Therapiessuch As Adp A2M4 For Synovial Sarcoma And Ovarian Canceradp A2M10 For Melanoma And Lung Cancerand Adp A2Afp For Liver Cancerthe Company Conducts Global Phase I Ii Trials And Has A Fully Integrated Manufacturing Infrastructure To Support Personalized Cell Therapy Productionadaptimmune Collaborates With Academic Institutions And Investorsemphasizing A Patient Centric Approach In Its Mission To Improve Patient Outcomes Through Innovative Cell Therapies
